.png)
A few years ago, most people had never heard of a GLP-1 medication. Now the names show up everywhere: in the news, on social media, in conversations with friends and family. Ozempic. Wegovy. Mounjaro. Zepbound. It's a lot of brand names for what sounds like it should be a simple category of medication, and the overlap between them causes a lot of confusion.
Here's the thing: these medications aren't interchangeable, and they're not one-size-fits-all. Some are approved for type 2 diabetes. Some are approved for weight management. Some are the exact same drug sold under two different names, for two different purposes. Let's sort out what's actually going on.
GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally produces after you eat. It does a few important jobs: it tells your pancreas to release insulin, slows down how quickly food leaves your stomach, and signals to your brain that you're full.
GLP-1 medications are lab-made versions of that hormone (or, in some cases, versions that act on GLP-1 and other related receptors). They mimic what your body already does, just with a stronger and longer-lasting effect. That's why they help regulate blood sugar and also tend to reduce appetite and food intake.
This is where most of the confusion comes from, so let's go drug by drug.
Semaglutide (Ozempic and Wegovy)Ozempic and Wegovy contain the same active ingredient: semaglutide. The difference is what they're approved for and the maximum dose available. Ozempic is FDA-approved for type 2 diabetes management. Wegovy is FDA-approved for chronic weight management. They're manufactured by the same company, work the same way in the body, and are often prescribed off-label across categories depending on a patient's clinical picture, according to a comparison from WebMD.
There's also Rybelsus, an oral form of semaglutide, for people who'd rather take a daily pill than a weekly injection.
Tirzepatide (Mounjaro and Zepbound)Mounjaro and Zepbound both contain tirzepatide, but tirzepatide works a bit differently than semaglutide. It's a dual-action medication, targeting both GLP-1 and a second hormone receptor called GIP (glucose-dependent insulinotropic polypeptide). Mounjaro is approved for type 2 diabetes, while Zepbound is approved for weight management. In head-to-head data, tirzepatide has shown some of the most significant average weight loss results among currently available GLP-1 and dual-agonist medications, per reporting from both WebMD and GoodRx.
Other GLP-1 OptionsOlder GLP-1 medications like Trulicity (dulaglutide) and Victoza (liraglutide) are still commonly prescribed for type 2 diabetes, though they tend to produce less weight loss than the newer semaglutide and tirzepatide options. There are also newer medications in this class continuing to enter the market, with more options and formulations expected in the coming years.
A few key factors separate these medications from each other:
GLP-1 medications share a fairly similar side effect profile, most commonly:
These effects are usually most noticeable in the first several weeks and tend to improve as your body adjusts, particularly when doses are increased gradually under medical supervision. Less common but more serious risks exist too, which is exactly why starting and adjusting these medications should always happen with a provider tracking your response, not through guesswork.
GLP-1 medications are expensive, and insurance coverage varies widely depending on your plan, your diagnosis, and whether the prescription is for diabetes or weight management specifically. Manufacturer savings programs can sometimes help offset costs for eligible patients. If cost is a concern, it's worth a direct conversation with your provider about coverage, alternatives, and what's realistic for your situation.
With so much noise online, it's tempting to land on a brand name based on what a friend used or what's trending on social media. But the right GLP-1 option, if any, depends on your health history, your current medications, your goals, and how your body responds over time. What works well for one person's metabolism and side effect tolerance might not be the right fit for someone else.
This is exactly where Florida telehealth GLP-1 care makes a real difference. At Core Metabolic Health Clinic, care starts with a full picture of your health, not just a medication request. That means reviewing your labs, your history, and your goals with a provider who can talk through the options honestly, including whether a GLP-1 medication is the right tool for you at all. Follow-up happens on a schedule that fits your life, so dose adjustments and side effects get addressed quickly instead of waiting months between check-ins.
Ozempic, Wegovy, Mounjaro, and Zepbound aren't four different mystery drugs. They're variations of two active ingredients, approved for different purposes, with meaningful differences in dosing and results. Understanding those differences helps you ask better questions and make a more informed decision with your provider.
Core Metabolic Health Clinic provides Florida telehealth GLP-1 and weight management care, pairing clinical expertise with nutrition support so treatment decisions are based on your full health picture, not just a brand name.